Terms: = Prostate cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Prognosis
104 results:
1. Printing of 3D biomimetic structures for the study of bone metastasis: A review.
Khanmohammadi M; Volpi M; Walejewska E; Olszewska A; Swieszkowski W
Acta Biomater; 2024 Apr; 178():24-40. PubMed ID: 38458512
[TBL] [Abstract] [Full Text] [Related]
2. Optimal systemic therapy in men with low-volume prostate cancer.
Saxena A; Andrews J; Bryce AH; Riaz IB
Curr Opin Urol; 2024 May; 34(3):183-197. PubMed ID: 38445371
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis.
Puche-Sanz I; Chiu P; Morillo AC; Gomez-Gomez E;
Curr Opin Urol; 2023 Nov; 33(6):472-481. PubMed ID: 37747431
[TBL] [Abstract] [Full Text] [Related]
4. Research on texture images and radiomics in urology: a review of urological MR imaging applications.
Valeri A; Nguyen TA
Curr Opin Urol; 2023 Nov; 33(6):428-436. PubMed ID: 37727910
[TBL] [Abstract] [Full Text] [Related]
5. A spectroscopic liquid biopsy for the earlier detection of multiple cancer types.
Cameron JM; Sala A; Antoniou G; Brennan PM; Butler HJ; Conn JJA; Connal S; Curran T; Hegarty MG; McHardy RG; Orringer D; Palmer DS; Smith BR; Baker MJ
Br J Cancer; 2023 Nov; 129(10):1658-1666. PubMed ID: 37717120
[TBL] [Abstract] [Full Text] [Related]
6. Use of genomic markers to improve epidemiologic and clinical research in urology.
Cancel-Tassin G; Koutros S
Curr Opin Urol; 2023 Nov; 33(6):414-420. PubMed ID: 37642472
[TBL] [Abstract] [Full Text] [Related]
7. Analyzing roles of small nucleolar RNA host gene 25 from clinical, molecular target and tumor formation in prostate cancer.
Liu Z; Ke S; Wang Q; Gu X; Zhai G; Shao H; He M; Guo J
Exp Cell Res; 2023 Aug; 429(2):113686. PubMed ID: 37307941
[TBL] [Abstract] [Full Text] [Related]
8. Bait-trap chip for accurate and ultrasensitive capture of living circulating tumor cells.
Jiang W; Han L; Li G; Yang Y; Shen Q; Fan B; Wang Y; Yu X; Sun Y; He S; Du H; Miao J; Wang Y; Jia L
Acta Biomater; 2023 May; 162():226-239. PubMed ID: 36940769
[TBL] [Abstract] [Full Text] [Related]
9. Qingdai Decoction suppresses prostate cancer growth in lethal-stage prostate cancer models.
Chen Y; Zhou Q; Zhang H; Xu L; Lu L; Shu B; Zhou L; Yuan F
J Ethnopharmacol; 2023 May; 308():116333. PubMed ID: 36863640
[TBL] [Abstract] [Full Text] [Related]
10. Direct comparison between Grade Group assessed on systematic and MRI/ultrasound fusion targeted biopsies correlated to the radical prostatectomy specimens in patients with prostate cancer.
Payrard-Starck C; Fourcade A; An Nguyen T; Tissot V; Doucet L; Marolleau J; Lucas C; Fournier G; Valeri A
Prog Urol; 2023 Apr; 33(5):265-271. PubMed ID: 36740508
[TBL] [Abstract] [Full Text] [Related]
11. The Microbiome's Influence on Head and Neck cancers.
Dorobisz K; Dorobisz T; Zatoński T
Curr Oncol Rep; 2023 Mar; 25(3):163-171. PubMed ID: 36696075
[TBL] [Abstract] [Full Text] [Related]
12. Total flavonoids of Litchi seed attenuate stem cell-like properties in breast cancer by regulating Notch3 signaling pathway.
Liao Y; Luo Z; Liu Y; Xue W; He S; Chen X; Ren H; Yang X; Zhu D; Su Z; Huang Q; Guo H
J Ethnopharmacol; 2023 Apr; 305():116133. PubMed ID: 36603788
[TBL] [Abstract] [Full Text] [Related]
13. Plant-Based Diets and cancer prognosis: a Review of Recent Research.
Hardt L; Mahamat-Saleh Y; Aune D; Schlesinger S
Curr Nutr Rep; 2022 Dec; 11(4):695-716. PubMed ID: 36138327
[TBL] [Abstract] [Full Text] [Related]
14. Histological patterns, subtypes and aspects of prostate cancer: different aspects, different outcomes.
Wasinger G; Oszwald A; Shariat SF; Compérat E
Curr Opin Urol; 2022 Nov; 32(6):643-648. PubMed ID: 36081403
[TBL] [Abstract] [Full Text] [Related]
15. Metabolic syndrome, obesity and cancer risk.
Belladelli F; Montorsi F; Martini A
Curr Opin Urol; 2022 Nov; 32(6):594-597. PubMed ID: 36081396
[TBL] [Abstract] [Full Text] [Related]
16. Advanced imaging and theranostics in thyroid cancer.
Roseland ME; Dewaraja YK; Wong KK
Curr Opin Endocrinol Diabetes Obes; 2022 Oct; 29(5):456-465. PubMed ID: 36068937
[TBL] [Abstract] [Full Text] [Related]
17. SERUM ANTIBODIES AGAINST GroEL AS AN ADDITIONAL RISK BIOMARKER OF BIOCHEMICAL RECURRENCE AFTER RADICAL prostateCTOMY.
Grygorenko V; Afanasiev Y; Danylets R; Vikarchuk M; Shulyak O
Exp Oncol; 2022 Aug; 44(2):163-168. PubMed ID: 35964651
[TBL] [Abstract] [Full Text] [Related]
18. Interventions to Reduce Sedentary Behavior in cancer Patients and Survivors: a Systematic Review.
Belcher BR; Kang DW; Yunker AG; Dieli-Conwright CM
Curr Oncol Rep; 2022 Nov; 24(11):1593-1605. PubMed ID: 35829982
[TBL] [Abstract] [Full Text] [Related]
19. Molecular Landscape of LncRNAs in prostate cancer: A focus on pathways and therapeutic targets for intervention.
Mirzaei S; Paskeh MDA; Okina E; Gholami MH; Hushmandi K; Hashemi M; Kalu A; Zarrabi A; Nabavi N; Rabiee N; Sharifi E; Karimi-Maleh H; Ashrafizadeh M; Kumar AP; Wang Y
J Exp Clin Cancer Res; 2022 Jul; 41(1):214. PubMed ID: 35773731
[TBL] [Abstract] [Full Text] [Related]
20. Integration of Liquid Biopsies in Clinical Management of Metastatic prostate cancer.
Tulpule V; Morrison GJ; Falcone M; Quinn DI; Goldkorn A
Curr Oncol Rep; 2022 Oct; 24(10):1287-1298. PubMed ID: 35575959
[TBL] [Abstract] [Full Text] [Related]
[Next]
